Moderna, Inc. (MRNA)
59.90
-1.92
(-3.11%)
USD |
NASDAQ |
Jul 20, 15:31
Moderna Price to Book Value : 3.210 for July 20, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 17, 2026 | 3.313 |
| July 16, 2026 | 3.384 |
| July 15, 2026 | 3.659 |
| July 14, 2026 | 3.614 |
| July 13, 2026 | 3.591 |
| July 10, 2026 | 3.659 |
| July 09, 2026 | 4.103 |
| July 08, 2026 | 3.955 |
| July 07, 2026 | 4.275 |
| July 06, 2026 | 4.384 |
| July 02, 2026 | 4.274 |
| July 01, 2026 | 3.885 |
| June 30, 2026 | 3.753 |
| June 29, 2026 | 3.735 |
| June 26, 2026 | 3.605 |
| June 25, 2026 | 3.202 |
| June 24, 2026 | 3.238 |
| June 23, 2026 | 3.269 |
| June 22, 2026 | 3.180 |
| June 18, 2026 | 3.428 |
| June 17, 2026 | 3.312 |
| June 16, 2026 | 2.969 |
| June 15, 2026 | 2.794 |
| June 12, 2026 | 2.675 |
| June 11, 2026 | 2.660 |
| Date | Value |
|---|---|
| June 10, 2026 | 2.465 |
| June 09, 2026 | 2.558 |
| June 08, 2026 | 2.551 |
| June 05, 2026 | 2.542 |
| June 04, 2026 | 2.765 |
| June 03, 2026 | 2.629 |
| June 02, 2026 | 2.446 |
| June 01, 2026 | 2.468 |
| May 29, 2026 | 2.529 |
| May 28, 2026 | 2.549 |
| May 27, 2026 | 2.552 |
| May 26, 2026 | 2.520 |
| May 22, 2026 | 2.512 |
| May 21, 2026 | 2.533 |
| May 20, 2026 | 2.579 |
| May 19, 2026 | 2.450 |
| May 18, 2026 | 2.578 |
| May 15, 2026 | 2.628 |
| May 14, 2026 | 2.681 |
| May 13, 2026 | 2.702 |
| May 12, 2026 | 2.855 |
| May 11, 2026 | 2.834 |
| May 08, 2026 | 2.913 |
| May 07, 2026 | 2.601 |
| May 06, 2026 | 2.615 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioNTech SE | 1.078 |
| Kailera Therapeutics, Inc. | -- |
| Replimune Group, Inc. | 5.227 |
| Sarepta Therapeutics, Inc. | 1.190 |
| Erasca, Inc. | 15.14 |
Price to Book Value Related Metrics
| PS Ratio | 10.53 |
| Price | 59.90 |
| Earnings Yield | -13.60% |
| Market Cap | 23.78B |